Acute effects of fructose consumption on uric acid, serum antioxidant capacity and inflammatory response.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017107

Enrollment

Unknown

Registered

2018-07-12

Start date

2018-12-01

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic disease

Interventions

High-dose group:Fructose

Medium-dose group:Fructose

Low-dose group :Fructose

Control group:Glucose

Eligibility

Sex/Gender

All

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Voluntary participation; (2) Health volunteer aged 18-35 years; (3) No Use of drugs which affect serum glucose, lipid and uric acid; (4) Inform Consent Form.

Exclusion criteria

Exclusion criteria: 1. Fructose intolerance, BMI < 18Kg/m2, diabetes, gout, hypertension, dyslipidemia, Chronic inflammatory disease or immunosuppressive therapy; 2. Participate in other trials during last 3 months; 3. Psychosis; 4. Allergy.

Design outcomes

Primary

Measure	Time frame
Uric acid;Serum antioxidant capacity;Inflammatory factor;	—

Countries

China

Contacts

Public ContactZhao Wei

Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University

niexiuling001@126.com+86 13820103741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026